Combined DLL3-targeted bispecific antibody with PD-1 inhibition is efficient to suppress small cell lung cancer growthXin Chen(Johns Hopkins University), Mingqian Feng(Huazhong Agricultural University)Journal for ImmunoTherapy of CancerJune 1, 202010.1136/jitc-2020-000785Cited by 73SaveCiteExport RISWatch citationsRelated PapersMolecular profiling identifies distinct subtypes across TP53 mutant tumors|JCI Insight|2022|9Generation of TIM3 inhibitory single‑domain antibodies to boost the antitumor activity of chimeric antigen receptor T cells|Oncology Letters|2021|3